Treatment of acquired hemophilia A, a balancing act: results from a 27‐year Dutch cohort study

Acquired hemophilia A (AHA) is a severe auto‐immune bleeding disorder. Treatment of AHA is burdensome and optimal management is still unresolved. Therefore a retrospective nationwide multi‐center cohort study (1992‐2018) was performed to evaluate clinical presentation and treatment efficacy and safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Schep, Sarah J., van Dijk, Wobke E. M., Beckers, Erik A. M., Meijer, Karina, Coppens, Michiel, Eikenboom, Jeroen, Leebeek, Frank W. G., van Vulpen, Lize F. D., Fischer, Kathelijn F., Schutgens, Roger E. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756759/
https://www.ncbi.nlm.nih.gov/pubmed/32974947
http://dx.doi.org/10.1002/ajh.26009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756759/
https://www.ncbi.nlm.nih.gov/pubmed/32974947
http://dx.doi.org/10.1002/ajh.26009

Ejemplares similares